Fig. 4.
Fig. 4. Progression-free survival of 104 patients with non-Hodgkin lymphoma after ASCT as a function of ALC recovery at day 15. / Median progression-free survival for patients with an ALC less than 500 cells/μL was 4 months. For patients with an ALC greater than or equal to 500 cells/μL, the median progression-free survival has not been reached (P < .0001).

Progression-free survival of 104 patients with non-Hodgkin lymphoma after ASCT as a function of ALC recovery at day 15.

Median progression-free survival for patients with an ALC less than 500 cells/μL was 4 months. For patients with an ALC greater than or equal to 500 cells/μL, the median progression-free survival has not been reached (P < .0001).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal